Application of CE–MS to A Metabonomics Study of Human Urine from Cigarette Smokers and Non-Smokers
Authors:
- 1 October 2014
- journal article
- Published by Taylor & Francis in Bioanalysis
- Vol. 6 (20) , 2733-2749
Abstract
Novel biomarkers of exposure and early adverse effects are needed for comparative studies of combustible and non-combustible tobacco products for regulatory authority evaluation. Metabolic biomarkers reflect both gene and environmental effects. CE-MS has been applied to human urine samples from non-smokers and smokers of cigarettes at two tar levels. Validated chemometric models were able to separate smokers from non-smokers, with discrimination mainly based on the presence of nicotine metabolites. With these removed, it still proved possible to discriminate smokers from non-smokers with models now based on endogenous metabolites. The biochemical relevance of these biomarkers is discussed. This proof-of-principle metabonomics study illustrates the potential of CE-MS to discover novel biomarkers in urine from tobacco users.Keywords
This publication has 71 references indexed in Scilit:
- Feasibility of Identifying the Tobacco-related Global Metabolome in Blood by UPLC–QTOF-MSJournal of Proteome Research, 2013
- Systematic Evaluation of Extraction Methods for Multiplatform-Based Metabotyping: Application to the Fasciola hepatica MetabolomeAnalytical Chemistry, 2012
- Lung glutathione adaptive responses to cigarette smoke exposureRespiratory Research, 2011
- Serum metabolomics as a novel diagnostic approach for gastrointestinal cancerBiomedical Chromatography, 2011
- Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolismProceedings of the National Academy of Sciences, 2009
- Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition researchMetabolomics, 2009
- HMDB: a knowledgebase for the human metabolomeNucleic Acids Research, 2008
- High‐resolution magic angle spinning MRS of breast cancer tissueNMR in Biomedicine, 2002
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999